Skip to main content

Table 1 Changes in urinary protein, BUN, and Scr in each group (\(\overline{x}\)±s, n = 10)

From: Complement C3 mediates podocyte injury through TLR4/NFΚB-P65 signaling during ischemia–reperfusion acute kidney injury and post-injury fibrosis

 

Group

D0

D1

D2

D3

D7

D14

D28

UPE (mg/d)

Sham

1.39 ± 0.19

1.43 ± 0.17

1.45 ± 0.18

1.44 ± 0.19

1.432 ± 0.16

1.41 ± 0.17

1.52 ± 0.27

 

AKI-CKD

1.41 ± 0.15

1.91 ± 0.33

1.96 ± 0.27

2.22 ± 0.35**##

3.81 ± 1.23**##

12.05 ± 2.38**##

17.79 ± 2.86**##

BUN(mmol/L)

Sham

11.21 ± 1.25

11.01 ± 1.03

11.88 ± 0.69

11.92 ± 1.27

12.51 ± 1.42

12.15 ± 1.41

11.97 ± 1.55

 

AKI-CKD

11.34 ± 1.37

29.97 ± 2.12**##

16.53 ± 1.24**##

22.79 ± 313**##

25.45 ± 2.99**##

29.68 ± 1.45**##

48.06 ± 6.72**##

Scr(umol/L)

Sham

7.08 ± 0.82

7.15 ± 0.72

7.19 ± 0.91

7.07 ± 0.81

7.12 ± 0.83

6.98 ± 0.69

7.25 ± 0.94

 

AKI-CKD

7.43 ± 0.73

18.11 ± 1.68**##

11.75 ± 1.27**##

13.97 ± 1.79**##

15.68 ± 1.35**##

24.01 ± 1.29**##

35.61 ± 3.08**##

  1. UPE urinary protein excretion, BUN serum urea nitrogen, Scr serum creatinine
  2. *P < 0.05 vs Sham, **P < 0.01 vs Sham, #P < 0.05 vs D0, ##P < 0.01vs D0